Skip to main content
PROCTER & GAMBLE HEALTH LIMITED logo

PROCTER & GAMBLE HEALTH LIMITED — Investor Relations & Filings

Ticker · PGHL ISIN · INE199A01012 LEI · 3358008EZOXHCL1OF384 BSE.NS Manufacturing
Filings indexed 1,273 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country IN India
Listing BSE.NS PGHL

About PROCTER & GAMBLE HEALTH LIMITED

https://www.pghealthindia.com/

Procter & Gamble Health Limited specializes in the manufacturing and marketing of over-the-counter (OTC) pharmaceutical products, vitamins, minerals, and supplements. The company focuses on key therapeutic areas including nerve care, bone health, muscle health, and respiratory wellness. Its product portfolio features globally recognized brands such as Neurobion, Polybion, Evion, Seven Seas, and Nasivion. By integrating scientific innovation with consumer insights, the organization provides healthcare solutions aimed at addressing nutritional deficiencies and common ailments. The company operates with a commitment to quality and efficacy, delivering products designed to support long-term health and daily well-being for a broad consumer base.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It informs about the sale of immovable properties by the company and the expected profit from the transaction. The content is an update on a specific corporate event (sale of assets) rather than a financial report, earnings release, or management discussion. It is a regulatory announcement about a material event affecting the company, fitting the category of a general regulatory filing. The document length is short (1423 characters), and it does not contain financial statements or detailed analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report being published or attached. Therefore, the best classification is Regulatory Filings (RNS).
2026-04-30 English
Dear Sir, Please find attached our intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015. Request you to kindly take the same on record.
Regulatory Filings
2026-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-06 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-06 English
Dear Sir/Madam, Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended March 31, 2026.
Regulatory Filings
2026-04-06 English
Trading Window
Regulatory Filings
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.